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Heme oxygenase-1 
protects podocytes  
in diabetes
The role of oxidant injury is now 
thought to be a common denomina-
tor in many, if not all, inflammatory 
and toxic diseases. Heme oxygenase-1 
(HO-1) is an antioxidant enzyme nor-
mally upregulated in response to oxi-
dant injury. As they report in this issue, 
Lee et al. induced diabetes in rats and 
found an increase in apoptosis of podo-
cytes in their glomeruli. Accompanying 
or preceding these events was upregu-
lation of HO-1 as well as several of the 
enzymes that cause apoptosis, such as 
caspase-3. The changes were blocked 
in cultured podocytes treated with 
high glucose by small interfering RNA 
for HO-1. In vivo, treatment of the dia-
betic rats with zinc protoporphyrin—
an agent thought to act upstream 
of HO-1—reduced the number of 
apoptotic cells in the diabetic glomeruli. 
These results provide a direct test for 
the role of HO-1 in glomerular disease 




The plasma level of cortisol is an order 
of magnitude higher than that of aldos-
terone, but its affinity to the mineralo-
corticoid receptor is similar to that of 
aldosterone. Aldosterone is the actual 
mineralocorticoid due to the presence 
of the enzyme 11b-hydroxy-steroid 
dehydrogenase II, which converts cor-
tisol into an inactive steroid and allows 
aldosterone to bind to its receptor in 
target tissues such as the collecting 
duct and colon. In a new study, Farese 
et al. treated 10 patients with ESRD 
with glycyrrhetinic acid derived from 
licorice, an inhibitor of the enzyme. 
This treatment allows cortisol as well 
as aldosterone to act on the major 
remaining aldosterone target tissue: 
the colon. Most patients demonstrated 
a reduction in serum potassium (K) 
before dialysis and in the frequency of 
severe hyperkalemia before dialysis. 
The study was conducted for 6 months; 
long-term studies are needed before 
the routine use of this treatment can be 
recommended. See page 877.
AKI predicts  
severity in MI
Acute myocardial infarction (MI) is 
often associated with acute kidney 
injury (AKI). To study its incidence 
and clinical significance, Goldberg et 
al. report on almost 2000 patients who 
survived an MI. A spectrum of elevated 
serum creatinine levels was found after 
MIs that occurred during hospitali-
zation. Mild elevations, as expected, 
were transient. Creatinine elevations 
of more than 0.5 mg/dl above base-
line were found in 138 patients and 
were transient in 60 of them. As com-
pared with patients without AKI, the 
adjusted hazard ratio for mortality was 
1.2 in patients with mild, transient AKI 
and 1.8 in patients with mild, persist-
ent injury wherein creatinine levels 
remained elevated. Patients with per-
sistent moderate/severe AKI had the 
highest mortality (hazard ratio 2.4). A 
similar relationship was present between 
AKI and admissions for heart failure. 
This study shows that the response of 
the kidney to acute MI is an excellent 
barometer of the health of the cardio-
vascular system. See page 900.
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
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